Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert N Foley

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis|September 18, 2009
Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first"Robert N Foley, Shu-Cheng Chen, Allan J Collins
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 22, 2007
Pneumonia in incident dialysis patients--the United States Renal Data SystemHaifeng Guo, Jiannong Liu, Allan J Collins, et al.
Journal of the American Society of Nephrology : JASN|July 28, 2007
NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalitiesRobert N Foley, Changchun Wang, Areef Ishani, et al.
Kidney International|February 12, 2004
Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?Areef Ishani, Charles A Herzog, Allan J Collins, et al.
American Heart Journal|September 2, 2008
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) StudyRobert N Foley, Allan J Collins, Areef Ishani, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANESRobert N Foley, Changchun Wang, Jon J Snyder, et al.
The New England Journal of Medicine|October 14, 2011
Long interdialytic interval and mortality among patients receiving hemodialysisRobert N Foley, David T Gilbertson, Thomas Murray, et al.
Kidney International|June 16, 2005
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 studyAreef Ishani, Allan J Collins, Charles A Herzog, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Hemodialysis International. International Symposium on Home Hemodialysis|September 18, 2009
Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first"Robert N Foley, Shu-Cheng Chen, Allan J Collins
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 22, 2007
Pneumonia in incident dialysis patients--the United States Renal Data SystemHaifeng Guo, Jiannong Liu, Allan J Collins, et al.
Journal of the American Society of Nephrology : JASN|July 28, 2007
NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalitiesRobert N Foley, Changchun Wang, Areef Ishani, et al.
Kidney International|February 12, 2004
Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?Areef Ishani, Charles A Herzog, Allan J Collins, et al.
American Heart Journal|September 2, 2008
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) StudyRobert N Foley, Allan J Collins, Areef Ishani, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANESRobert N Foley, Changchun Wang, Jon J Snyder, et al.
The New England Journal of Medicine|October 14, 2011
Long interdialytic interval and mortality among patients receiving hemodialysisRobert N Foley, David T Gilbertson, Thomas Murray, et al.
Kidney International|June 16, 2005
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 studyAreef Ishani, Allan J Collins, Charles A Herzog, et al.
Pageof 16